Parallel Advisors’s Allogene Therapeutics ALLO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-114
| Closed | -$166 | – | 3515 |
|
|
2025
Q1 | $166 | Sell |
114
-107
| -48% | -$156 | ﹤0.01% | 3392 |
|
|
2024
Q4 | $471 | Hold |
221
| – | – | ﹤0.01% | 3210 |
|
|
2024
Q3 | $619 | Hold |
221
| – | – | ﹤0.01% | 3128 |
|
|
2024
Q2 | $515 | Buy |
+221
| New | +$515 | ﹤0.01% | 3076 |
|
|
2024
Q1 | – | Sell |
-32
| Closed | -$103 | – | 3274 |
|
|
2023
Q4 | $103 | Sell |
32
-536
| -94% | -$1.73K | ﹤0.01% | 3226 |
|
|
2023
Q3 | $1.8K | Buy |
568
+230
| +68% | +$729 | ﹤0.01% | 2858 |
|
|
2023
Q2 | $1.68K | Buy |
338
+40
| +13% | +$199 | ﹤0.01% | 2800 |
|
|
2023
Q1 | $1.47K | Hold |
298
| – | – | ﹤0.01% | 2858 |
|
|
2022
Q4 | $1.87K | Buy |
298
+174
| +140% | +$1.09K | ﹤0.01% | 2709 |
|
|
2022
Q3 | $1K | Sell |
124
-464
| -79% | -$3.74K | ﹤0.01% | 2810 |
|
|
2022
Q2 | $7K | Sell |
588
-286
| -33% | -$3.41K | ﹤0.01% | 2099 |
|
|
2022
Q1 | $8K | Sell |
874
-402
| -32% | -$3.68K | ﹤0.01% | 2085 |
|
|
2021
Q4 | $19K | Hold |
1,276
| – | – | ﹤0.01% | 1794 |
|
|
2021
Q3 | $33K | Sell |
1,276
-389
| -23% | -$10.1K | ﹤0.01% | 1467 |
|
|
2021
Q2 | $43K | Buy |
1,665
+400
| +32% | +$10.3K | ﹤0.01% | 1296 |
|
|
2021
Q1 | $45K | Hold |
1,265
| – | – | ﹤0.01% | 1208 |
|
|
2020
Q4 | $32K | Sell |
1,265
-134
| -10% | -$3.39K | ﹤0.01% | 1263 |
|
|
2020
Q3 | $53K | Buy |
1,399
+477
| +52% | +$18.1K | ﹤0.01% | 1022 |
|
|
2020
Q2 | $39K | Sell |
922
-130
| -12% | -$5.5K | ﹤0.01% | 1137 |
|
|
2020
Q1 | $20K | Buy |
1,052
+800
| +317% | +$15.2K | ﹤0.01% | 1300 |
|
|
2019
Q4 | $7K | Hold |
252
| – | – | ﹤0.01% | 1835 |
|
|
2019
Q3 | $7K | Hold |
252
| – | – | ﹤0.01% | 1772 |
|
|
2019
Q2 | $7K | Hold |
252
| – | – | ﹤0.01% | 1680 |
|
|
2019
Q1 | $7K | Buy |
+252
| New | +$7K | ﹤0.01% | 1646 |
|